New study aims to reduce itching from labor pain relief
NCT ID NCT07187427
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at two common methods of giving fentanyl for pain relief during labor: one injected into the spinal fluid and the other into the epidural space. The goal is to see which method causes less itching, a frequent side effect. Researchers will track itching severity and other side effects like nausea and low blood pressure in 80 women giving birth vaginally.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fentanyl
What this could lead to
If this trial succeeds, it could help doctors choose the fentanyl injection method that causes less itching during labor, improving comfort for women in childbirth.
What could go wrong
This is a small, early-stage trial with only 80 participants, so results may not apply to all women. The study is not yet recruiting, and the outcome focuses on a side effect rather than a major health benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOTENSION DRUG-INDUCED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire de Sainte Justine
Montreal, Quebec, H3T 1C5, Canada
Contact